flutiform (fluticasone propionate formoterol): Reviews and patient testimonials

flutiform 50 microgram/5 microgram, 125 microgram/5 microgram and 250 microgram/10 microgram per actuation pressurised inhalation, suspension

This fixed-dose combination of fluticasone propionate and formoterol fumarate (flutiform inhaler) is indicated in the regular treatment of asthma where the use of a combination product (an inhaled corticosteroid and a long-acting β₂ agonist) is appropriate:

• For patients not adequately controlled with inhaled corticosteroids and 'as required' inhaled short-acting β₂ agonist.

Or

• For patients already adequately controlled on both an inhaled corticosteroid and a long-acting β₂ agonist.

flutiform 50 microgram /5 microgram and 125 microgram /5 microgram inhaler are indicated in adults and adolescents aged 12 years and above.

flutiform 250 microgram /10 microgram inhaler is indicated in adults only.

Route of administration: opinion.traitement.inhalation
Molecule: fluticasone propionate, formoterol